This challenge is addressed by GLP-1RAs, which mimic the actions of GLP-1 and have been shown to be a significant advancement in the treatment of T2DM, offering benefits beyond traditional glycemic control [75]. Here, GCG is linked to type 2 diabetes mellitus.